Patents by Inventor Kai-Yue CAO

Kai-Yue CAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid molecules and uses thereof
    Patent number: 11866704
    Abstract: A method of treating a subject suffering from cancer comprising a step of administering an effective amount of a group of double-stranded RNA molecules to the subject, wherein the RNA molecule is isolated or derived from a bacteria of the genus Escherichia. A method of inhibiting growth or proliferation of cancer cells comprising a step of contacting said cells with said RNA molecule; and a pharmaceutical composition for treating cancer comprising said RNA molecule and a pharmaceutically tolerable excipient. Also a double-stranded RNA molecule and a recombinant vector comprising the double-stranded RNA molecule.
    Type: Grant
    Filed: December 6, 2020
    Date of Patent: January 9, 2024
    Assignee: Macau University of Science and Technology
    Inventors: Zhi-Hong Jiang, Kai-Yue Cao, Yu Pan, Tong-Meng Yan
  • Method and pharmaceutical composition for treating cancer
    Patent number: 11149271
    Abstract: A method of treating a subject suffering from cancer includes administering an effective amount of a RNA molecule to the subject, wherein the RNA molecule is isolated or derived from a plant of the genus Taxus. A method of inhibiting growth or proliferation of cancer cells includes contacting cancer cells with the RNA molecule; and a pharmaceutical composition for treating cancer includes the RNA molecule and a pharmaceutically tolerable excipient. Also a double-stranded RNA molecule and a recombinant vector include the double-stranded RNA molecule.
    Type: Grant
    Filed: September 4, 2018
    Date of Patent: October 19, 2021
    Inventors: Zhi-Hong Jiang, Tong-Meng Yan, Kai-Yue Cao
  • Nucleic Acid Molecules and Uses Thereof
    Publication number: 20210254066
    Abstract: A method of treating a subject suffering from cancer comprising a step of administering an effective amount of a group of double-stranded RNA molecules to the subject, wherein the RNA molecule is isolated or derived from a bacteria of the genus Escherichia. A method of inhibiting growth or proliferation of cancer cells comprising a step of contacting said cells with said RNA molecule; and a pharmaceutical composition for treating cancer comprising said RNA molecule and a pharmaceutically tolerable excipient. Also a double-stranded RNA molecule and a recombinant vector comprising the double-stranded RNA molecule.
    Type: Application
    Filed: December 6, 2020
    Publication date: August 19, 2021
    Inventors: Zhi-Hong JIANG, Kai-Yue CAO, Yu PAN, Tong-Meng YAN
  • METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING CANCER
    Publication number: 20200071695
    Abstract: A method of treating a subject suffering from cancer includes administering an effective amount of a RNA molecule to the subject, wherein the RNA molecule is isolated or derived from a plant of the genus Taxus. A method of inhibiting growth or proliferation of cancer cells includes contacting cancer cells with the RNA molecule; and a pharmaceutical composition for treating cancer includes the RNA molecule and a pharmaceutically tolerable excipient. Also a double-stranded RNA molecule and a recombinant vector include the double-stranded RNA molecule.
    Type: Application
    Filed: September 4, 2018
    Publication date: March 5, 2020
    Inventors: Zhi-Hong Jiang, Tong-Meng Yan, Kai-Yue CAO